Correction: Pharmacokinetics of post-transplant cyclophosphamide and its associations with clinical outcomes in pediatric haploidentical hematopoietic stem cell transplantation

Correction: Pharmacokinetics of post-transplant cyclophosphamide and its associations with clinical outcomes in pediatric haploidentical hematopoietic stem cell transplantation

Saved in:

Bibliographic Details
Main Authors:	Kyung Taek Hong, Sungyeun Bae, Yoon Sunwoo, Juyeon Lee, Hyun Jin Park, Bo Kyung Kim, Jung Yoon Choi, Joo-Youn Cho, Kyung-Sang Yu, Jaeseong Oh, Hyoung Jin Kang
Format:	Article
Language:	English
Published:	BMC 2025-04-01
Series:	Biomarker Research
Online Access:	https://doi.org/10.1186/s40364-025-00781-3
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Pharmacokinetics of post-transplant cyclophosphamide and its associations with clinical outcomes in pediatric haploidentical hematopoietic stem cell transplantation
by: Kyung Taek Hong, et al.
Published: (2025-03-01)

Post-transplant cyclophosphamide or cell selection in haploidentical allogeneic hematopoietic cell transplantation?
by: Razan Mohty, et al.
Published: (2024-12-01)

Haploidentical Stem Cell Transplantation With Dual Source of Cells and Post‐Transplant Cyclophosphamide
by: Ana Marcela Rojas Fonseca‐Hial, et al.
Published: (2025-02-01)

Post-transplant cyclophosphamide in haploidentical stem cell transplantation: evaluating the impact of transplant conditioning intensity
by: Umberto Pizzano, et al.
Published: (2025-08-01)

Early cardiac events after haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide. subanalysis exploring cardiac toxicity conducted on behalf of GETH-TC
by: Filipe R. Pinto, et al.
Published: (2025-05-01)

Future directions in haploidentical hematopoietic stem cell transplantation
by: Pongthep Vittayawacharin, et al.
Published: (2024-12-01)

Intermediate-dose posttransplantation cyclophosphamide for myeloablative HLA-haploidentical bone marrow transplantation
by: Mustafa A. Hyder, et al.
Published: (2025-05-01)

More about post-transplant cyclophosphamide in haploidentical grafts: full or reduced doses?
by: Moisés Manuel Gallardo-Pérez, et al.
Published: (2024-12-01)

Comparable Outcomes for Hematologic Malignancies after HLA-Haploidentical Transplantation with Posttransplantation Cyclophosphamide and HLA-Matched Transplantation
by: Shannon R. McCurdy, et al.
Published: (2015-01-01)

IMMUNITY TO INFECTIONS AFTER HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION
by: Franco Aversa, et al.
Published: (2016-10-01)

Current status of conditioning regimens in haploidentical hematopoietic cell transplantation
by: Junichi Sugita, et al.
Published: (2024-12-01)

Haploidentical Hematopoietic Stem Cell Transplantation: Expanding the Horizon for Hematologic Disorders
by: Mohammad Faizan Zahid, et al.
Published: (2016-01-01)

HAPLOIDENTICAL TRANSPLANT WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE FOR ACUTE MYELOID LEUKAEMIA AND MYELODYSPLASTIC SYNDROMES PATIENTS: THE ROLE OF PREVIOUS LINES OF THERAPY.
by: Daniele Avenoso, et al.
Published: (2024-01-01)

Myeloablative Conditioning with PBSC Grafts for T Cell-Replete Haploidentical Donor Transplantation Using Posttransplant Cyclophosphamide
by: Scott R. Solomon, et al.
Published: (2016-01-01)

Dual in vivo T cell depleted haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide and anti-thymocyte globulin as a third salvage transplant for leukocyte adhesion deficiency with graft failure: a case report
by: Azadeh Kiumarsi, et al.
Published: (2025-01-01)

Haploidentical stem cell transplantation with posttransplant cyclophosphamide in children with Wiskott–Aldrich syndrome: a case report
by: Le Nguyen Ngoc Quynh, et al.
Published: (2025-02-01)

HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR PAEDIATRIC PATIENTS WITH X-LINKED LYMPHOPROLIFERATIVE SYNDROME
by: Yuan Sun
Published: (2024-04-01)

Randomized trial of anti-thymocyte globulin plus low-dose post-transplant cyclophosphamide to prevent graft-versus-host disease in haploidentical transplantation
by: Zheng-Li Xu, et al.
Published: (2025-06-01)

The impact of tacrolimus levels on acute GVHD and transplant outcomes in haploidentical hematopoietic stem cell transplantation: A retrospective analysis
by: Alexander Nikoloudis, et al.
Published: (2025-08-01)

Paternal Split‐Liver Transplantation Followed by Haploidentical Hematopoietic Cell Transplantation in an Adult Patient With Protoporphyria‐Induced Liver Failure
by: Ulrich Stölzel, et al.
Published: (2025-02-01)

Haploidentical, matched-related, and matched-unrelated hematopoietic cell transplant for acute leukemias in the early years of haploidentical transplant implementation in a developing country with a large unrelated donor registry
by: Adriana Seber, et al.
Published: (2025-04-01)

Immune Reconstitution after Haploidentical Hematopoietic Stem Cell Transplantation with Different Non‐T‐Cell Depletion Protocols
by: Xiao‐Di Ma, et al.
Published: (2025-06-01)

Optimizing Haploidentical Hematopoietic Stem Cell Transplantation: Enhancing Outcomes in Hematologic Malignancies in Resource-Limited Settings
by: Owattanapanich W, et al.
Published: (2025-03-01)

Allogeneic hematopoietic stem cell transplantation for thalassemia major using matched unrelated donors and haploidentical related donors
by: Feiyan Wang, et al.
Published: (2025-02-01)

Effect of Hematopoietic Stem Cell Transplantation Regimen on Tacrolimus Pharmacokinetics
by: Haruno Oku, BS, et al.
Published: (2025-01-01)

HLA and Non-HLA Factors for Donor Selection in Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide GvHD Prophylaxis
by: Hiroko Shike, et al.
Published: (2024-12-01)

Low-dose anti-thymocyte globulin combined with low-dose post-transplant cyclophosphamide: a novel approach to prevent graft-versus-host disease in haploidentical stem cell transplantation
by: Neslihan Mandaci Ṣanli, et al.
Published: (2025-07-01)

Infectious Complications after Haploidentical Hematopoietic Stem Cells Transplantation in Patients with High-Risk Tumors of Hematopoietic and Lymphoid Tissues: A Single-Center Experience
by: YuS Osipov, et al.
Published: (2019-09-01)

Haploidentical Transplantation in Children with Acute Leukemia: The Unresolved Issues
by: Sarita Rani Jaiswal, et al.
Published: (2016-01-01)

Haploidentical Stem Cell Transplantation in Adult Haematological Malignancies
by: Kevon Parmesar, et al.
Published: (2016-01-01)

Impact of post-transplant cyclophosphamide with bendamustine on immune reconstitution in young patients undergoing T-cell replete haploidentical bone marrow transplantation: results from a phase Ia/Ib clinical trial
by: Forrest L. Baker, et al.
Published: (2025-04-01)

Impact of inhibitory KIR ligand mismatch and other variables on outcomes following myeloablative posttransplant cyclophosphamide-based T-cell-replete haploidentical bone marrow transplantation
by: Sarah Kayser, et al.
Published: (2024-12-01)

How to reduce the risk of primary engraftment failure after haploidentical hematopoietic stem cell transplantation in patients with acute myeloid leukemia?
by: D. K. Zhogolev, et al.
Published: (2025-03-01)

Hemorrhagic cystitis in pediatric severe aplastic anemia undergoing haploidentical hematopoietic stem cell transplantation: incidence, risk factors and outcomes
by: Kai Cui, et al.
Published: (2025-03-01)

Correction: Impact of post-transplant cyclophosphamide with bendamustine on immune reconstitution in young patients undergoing T-cell replete haploidentical bone marrow transplantation: results from a phase Ia/Ib clinical trial
by: Forrest L. Baker, et al.
Published: (2025-06-01)

Outcomes of haploidentical vs mismatched unrelated donor HCT with posttransplant cyclophosphamide prophylaxis
by: Yosra M. Aljawai, et al.
Published: (2025-08-01)

Successful Hematopoietic Stem Cell Transplantation Following a Cyclophosphamide-Containing Preparative Regimen with Concomitant Phenobarbital Administration
by: Catherine Weber, et al.
Published: (2012-01-01)

Triple stem cell infusion alleviated graft-versus-host disease and improves outcomes in unmanipulated haploidentical hematopoietic stem cell transplantation
by: Fang Hua, et al.
Published: (2025-07-01)

The rationale behind grafting haploidentical hematopoietic stem cells
by: Richard T. Maziarz, et al.
Published: (2024-12-01)

Immunogenicity and Antibody Persistence of the Inactivated Quadrivalent Influenza Vaccine in Pediatric Patients Post-Chemotherapy or Allogeneic Hematopoietic Stem Cell Transplantation Versus Healthy Controls
by: Mi Yeon Hur, et al.
Published: (2024-10-01)